EVIDENCE-BASED PROSPECTS FOR THE PREVENTIVE USE OF VITAMIN D


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

This review deals with the physiological and functional characteristics of vitamin D and its major metabolites, the ways of their synthesis and activation, the points of application and the main clinical effects. Special attention is paid to the analysis of available publications devoted to the evaluation of the effect of vitamin D on the prevention of development and progression of bone metabolism disorders, autoimmune and oncological diseases, diseases of the cardiovascular, nervous and reproductive systems.

Texto integral

Acesso é fechado

Sobre autores

A. Mikhaylova

FSBEI HE USMU of RMH

Email: mikhaylovamail@ya.ru
PhD, Teaching Assistant at the Department of Preventive and Family Medicine

A. Zakroyeva

FSBEI HE USMU of RMH

A. Sakhnin

FSBEI HE USMU of RMH

Bibliografia

  1. Glenville J., Strugnell S.A., DeLuca H.F. Current Understanding of the Molecular Actions of Vitamin D. Physiological Rev. 1998;78(4): 1193-231.
  2. Kimmel-Jehan C., Darwish H.M., Strugnell S.A., Jehan F., Wiefling B., DeLuca H.F. DNA binding is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements. J. Cell Biochem. 1999; 74:220-28.
  3. Ross A.C., Manson J.E., Abrams S.A., Aloia J.F., Brannon P.M., Clinton S.K., Durazo-Arvizu R.A., Gallagher J.C., Gallo R.L., Jones G., Kovacs C.S., Mayne S.T., Rosen C.J., Shapses S.A. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrin. Metab. 2011;96:53-8.
  4. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., Murad M.H., Weaver C.M. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrin. Metab. 2011;96:1911-30.
  5. Tucker G., Gagnon R.E., Haussler M.R. Vitamin D3-25-hydroxylase: tissue occurrence and lack of regulation. Archives of Biochemistry and. Biophysics.1997;155:47-57.
  6. Suda T., Ueno Y., Fujii K., Shinki T. Vitamin D and bone. J. Cell Biochem. 2002;88:259-66.
  7. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004;80(Suppl. 6):1689-96.
  8. Hypponen E., Laara E., Reunanen A., Jrvelin M.R., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2014;358:1500-503.
  9. Multiple Sclerosis Society Scotland. Shine on Scotland campaign Article, 24. April 2011.
  10. Bhalla A.K., Amento E.P., Clemens T.L., Holick M.F., Krane S.M. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrin. Metab. 1983;57:1308-10.
  11. Cantorna M.T., Hayes C.E., DeLuca H.F. 1.25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proceedings of the National Academic of Sciences in USA. 1996;93:7861-64.
  12. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. J. Am. Med. Association. 2006;296:2832-38.
  13. Zella J.B., DeLuca H.F Vitamin D and autoimmune diabetes. J. Cell Biochem. 2003;88:216-22.
  14. Lemire J.M., Ince A., Takashima M. 1.25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity. 1992;12:143-48.
  15. Nicholson A., Dalzell M., El-Matary W. Vitamin D as a therapy for colitis: A systematic review. J. Crohn's and Colitis. 2012;6(4):405-11.
  16. Cantorna M.T., Hayes C.E., DeLuca H.F. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J. Nutrition. 1998;128:68-72.
  17. Kalueff A.V., Minasyan A., Keisala T., Kuuslahti M., Miettinen S., Tuohimaa P. The vitamin D neuroendocrine system as a target for novel neurotropic drugs. CNS and Neurological Disorders-Drug Targets. 2006;5(3):363-71.
  18. Kerr D.R., Zava D.T., Piper W.T., Saturn S.R., Frei B., Gombart A.F. Associations between Vitamin D Levels and Depressive Symptoms in Healthy Young Adult Women. Psych. Res. 2015;227(1):46-51.
  19. Eyles D.W., Smith S., Kinobe R., Hewison M., McGrath J.J. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J. Chem. Neuroanatomy. 2005; 29(1):21-30.
  20. Kunzmann A.T., Cantwell M.M., Murray, L.J., Ng K., Carroll, D., Coleman, H.G. Vitamin D, Vitamin D Receptor Expression, Vitamin D-Related Gene Variants and Colorectal Cancer Progression. Syst. Rev. Nutrients. 2014;6(7):2759-919.
  21. Yao S., Kwan M.L., Ergas I.J., Roh J.M., Cheng T.D., Hong C.C., McCann S.E., Tang L., Davis W., Liu S., Quesenberry C.P. Jr, Lee M.M., Ambrosone C.B., Kushi L.H. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study. J. Am. Med. Association. Oncology. 2017; 3(3):351-57.
  22. Bjelakovic G., Gluud L.L., Nikolova D., Whitfield K., Krstic G., Wetterslev J., Gluud C. Vitamin D supplementation for prevention of cancer in adults. Cochrane Database Syst. Rev. 2014;(6):CD007469.
  23. Zittermann A., lodice S., Pilz S., Grant W.B., Bagnardi V., Gandini S. Vitamin D deficiency and mortality risk in the general population: a metaanalysis of prospective cohort studies. Am. J. Clin. Nutr. 2012;95(1):91-100.
  24. Michaëlsson K., Baron J.A., Snellman G., Gedeborg R., Byberg L., Sundström J., Berglund L., Arnlöv J., Hellman P., Blomhoff R., Wolk A., Garmo H., Holmberg L., Melhus H. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am. J. Clin. Nutr. 2010;92:841-48.
  25. Melamed M.L., Michos E.D., Post W., Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Int. Med. 2008;168:1629-37.
  26. Bjelakovic G., Gluud L.L., Nikolova D., Whitfield K., Wetterslev J., Simonetti R.G., Bjelakovic M., Gluud C. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst. Rev. 2014;(1):CD007470.
  27. McKenna M.J., Murray B.F., O'Keane M., Kilbane M.T. Rising trend in vitamin D status from 1993 to 2013: dual concerns for the future. Endocrine Connections. 2015;4(3):163-71.
  28. Hossein-nezhad A., Holick M.F. Vitamin D for Health: A Global Perspective. Mayo Clin. Proceed. 2013;88(7):720-55.
  29. Liu L., Chen M., Hankins S.R., Nùnez A.E., Watson R.A., Weinstock P.J., Newschaffer C.J., Eisen H.J. Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from allcause in United States adults. Am. J. Cardiol. 2012;110(6):834-39.
  30. Li Y.C., Qiao G., Uskokovic M., Xiang W., Zheng W., Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J. Steroid Biochem. Mol. Biol. 2004;1-5:89-90, 387-92.
  31. Burgaz A., Orsini N., Larsson S.C., Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J. Hypertension. 2011;29(4):636-45.
  32. Pittas A.G., Chung M., Trikalinos T., Mitri J., Brendel M., Patel K., Lichtenstein A.H., Lau J., Balk E.M. Systematic review: Vitamin D and cardiometabolic outcomes. Ann. Int. Med. 2010;152(5):307-14.
  33. Pillai S., Bikle D.D. Role of intracellular free calcium in the cornified envelope formation of keratinocytes: differences in the mode of action of extracellular calcium and 1,25 dihydroxyvitamin D. J. Cell Physiol. 1991;146:94-100.
  34. Dokoh S., Donaldson C.A., Marion S.L., Pike J.W., Haussler M.R. The ovary: a target organ for 1,25-dihydroxyvitamin D3. Endocrinol. 1983;112:200-6.
  35. Kaludjerovic J., Vieth R., Midwifery J. Relationship between vitamin D during perinatal development and health. Womens Health. 2010; 55(6):550-60.
  36. Holick M.F. Nutrition: D-iabetes and D-eath D-efying vitamin D. National Rev. Endocrinol. 2012;8(7):388-90.
  37. Lucas R.M., Ponsonby A.L., Pasco J.A., Morley R. Future health implications of prenatal and early-life vitamin D status. Nutr. Rev. 2008;66(12):710-20.
  38. Kim B.G., Chang S.K., Kim S.M., Hwang J.S., Jung J.W. Dilated cardiomyopathy in a 2 monthold infant: a severe form of hypocalcemia with vitamin d deficient rickets. Korean Circ. J. 2010;40(4):201-3.
  39. Maka N., Makrakis J., Parkington H.C., Tare M., Morley R., Black M.J. Vitamin D deficiency during pregnancy and lactation stimulates nephrogenesis in rat offspring. Ped. Nephrol. 2008;23(1):55-61.
  40. Eyles D., Brown J., Mackay-Sim A., McGrath J., Feron F. Vitamin D3 and brain development. Neuroscience. 2003;118(3):641-53.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2017

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies